for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Nova Eye Medical Ltd

EYE.AX

Latest Trade

0.33AUD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.28

 - 

0.79

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
0.33
Open
--
Volume
--
3M AVG Volume
2.12
Today's High
--
Today's Low
--
52 Week High
0.79
52 Week Low
0.28
Shares Out (MIL)
143.69
Market Cap (MIL)
48.85
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

更多

Nova Eye Medical Posts FY Net Profit After Tax A$35.6 Mln

Nova Eye Medical Updates On Australian Taxation Office Ruling On Capital Return

Lumibird Receives ACCC Go-Ahead To Buy Ellex's Laser And Ultrasound Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Nova Eye Medical Ltd

Nova Eye Medical Limited, formerly Ellex Medical Lasers Limited, is an Australia-based medical technology company. The Company develops, manufactures and sells a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye’s natural outflow pathway to lower pressure inside the eye. The Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control. It also provides retinal rejuvenation therapy (2RT) laser technology as a therapy for patients with intermediate age-related macular degeneration.

Industry

Medical Equipment & Supplies

Contact Info

3-4 Second Avenue

ADELAIDE, SA

5095

Australia

+61.8.81045200

http://www.ellex.com/

Executive Leadership

Victor Previn

Executive Chairman of the Board

Mike Southard

Executive Director

Simon Gray

Joint Company Secretary

Tom Spurling

Director

Alexander M. Sundich

Non-Executive Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
4.02
Price To Book (MRQ)
1.32
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
8.92
LT Debt To Equity (MRQ)
3.99
Return on Investment (TTM)
-16.89
Return on Equity (TTM)
-12.02

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up